₹28.60
−2.16%NSE close, 16 Nov 2026
−54.80%
Mangalam Drugs And Organics is a small cap company, listed on NSE under the symbol MANGALAM. At ₹28.60 a share, the market values the whole company at ₹45 crore.
In FY26, it reported sales of ₹232 crore and a net loss of ₹44 crore, an operating margin of -6.4%. Over the last three years, sales fell 19.9% a year.
The market values the company at 0.51 times its book value; its return on equity is -43.3% and its borrowings are 1.00 times its equity.
Promoters hold 35.65% of the shares. Foreign institutions hold 0.11%, and domestic institutions, mutual funds among them, 0.00%.
Over the past year the share price has fallen 55.2%, and it is 55.7% below its 52-week high.
₹ crore. Consolidated figures.
Submission of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026.
The financial results for the period ended September 30, 2026.
Appointment of Mr. Prabhakar Raghunath Zavar as Non- Executive Independent Director of the company w.e.f. September 15, 2026.
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 97.3 | 102 | 76.5 | 79.9 | 88.7 | 73.0 | 57.4 | 49.5 | 58.5 | 67.3 | 57.1 | 79.4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 90.4 | 90.5 | 68.4 | 71.2 | 79.9 | 62.9 | 61.8 | 52.4 | 59.9 | 72.9 | 56.2 | 80.5 |
| Operating profit | 7.0 | 11.7 | 8.2 | 8.7 | 8.8 | 10.2 | −4.5 | −2.8 | −1.4 | −5.6 | 0.9 | −1.2 |
| Operating margin | 7.2% | 11.4% | 10.7% | 10.9% | 9.9% | 13.9% | -7.8% | -5.7% | -2.4% | -8.4% | 1.6% | -1.4% |
| Other income | 0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.2 | 0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 |
| Interest | 3.3 | 4.0 | 3.8 | 3.7 | 3.5 | 4.0 | 4.0 | 5.0 | 4.1 | 3.1 | 3.7 | 3.9 |
| Depreciation | 3.6 | 3.9 | 3.9 | 4.0 | 4.1 | 4.7 | 4.5 | 4.6 | 4.5 | 4.7 | 4.1 | 4.1 |
| Profit before tax | 0.0 | 3.9 | 0.6 | 1.2 | 1.4 | 1.6 | −13.0 | −12.5 | −9.8 | −13.3 | −6.8 | −9.0 |
| Tax | −0.5 | 0.4 | −2.1 | −1.5 | 0.1 | 1.6 | 0.8 | −5.1 | 0 | 0.2 | 0.9 | −1.8 |
| Net profit | 0.5 | 3.5 | 2.7 | 2.7 | 1.3 | 0.1 | −13.8 | −7.4 | −9.8 | −13.4 | −7.6 | −7.2 |
| EPS (₹) | 0.31 | 2.23 | 1.70 | 1.70 | 0.81 | 0.04 | -8.72 | -4.64 | -6.21 | -8.48 | -4.83 | -4.55 |
₹ crore, financial years to March.
| Line | FY19 S | FY20 S | FY21 S | FY22 S | FY23 S | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Sales | 228 | 282 | 380 | 451 | 372 | 318 | 232 |
| Expenses | 218 | 259 | 327 | 402 | 347 | 282 | 247 |
| Operating profit | 9.7 | 23.7 | 53.3 | 49.1 | 25.5 | 35.8 | −14.9 |
| Operating margin | 4.3% | 8.4% | 14.0% | 10.9% | 6.9% | 11.3% | -6.4% |
| Other income | 0.3 | 1.2 | 4.7 | 0.1 | 0.4 | 0.5 | 0.8 |
| Interest | 8.7 | 10.4 | 9.3 | 11.2 | 12.8 | 14.9 | 16.2 |
| Depreciation | 7.1 | 8.2 | 9.2 | 10.3 | 11.0 | 16.6 | 18.2 |
| Profit before tax | −5.7 | 6.3 | 39.5 | 27.7 | 2.2 | 4.8 | −48.6 |
| Tax | 2.3 | −2.0 | 11.6 | 8.1 | 1.0 | −1.9 | −4.2 |
| Net profit | −8.0 | 8.3 | 28.0 | 19.7 | 1.3 | 6.7 | −44.4 |
| EPS (₹) | -5.07 | 5.21 | 17.67 | 12.42 | 0.83 | 4.25 | -28.05 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 30.7 | 42.6 | 4.2 | 23.4 |
| From investing | −27.3 | −19.5 | −11.7 | −1.7 |
| From financing | −2.0 | −21.7 | 5.7 | −21.6 |
| Spent on fixed assets | −27.7 | −20.2 | −11.9 | −1.8 |
| Free cash flow | 3.0 | 22.4 | −7.7 | 21.6 |
Margins, returns, debt, tax and cash.
| Line | FY19 | FY20 | FY21 | FY22 | FY23 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Net margin | -3.5% | 2.9% | 7.4% | 4.4% | 0.3% | 2.1% | -19.1% |
| Operating margin | 4.3% | 8.4% | 14.0% | 10.9% | 6.9% | 11.3% | -6.4% |
| Return on equity | – | – | – | – | 0.8% | 4.5% | -43.1% |
| Return on capital employed | – | – | – | – | 6.8% | 8.6% | -15.5% |
| Return on assets | – | – | – | – | 0.4% | 1.8% | -14.1% |
| Debt to equity | – | – | – | – | 0.45 | 0.54 | 1.02 |
| Interest coverage | 0.30 | 1.60 | 5.20 | 3.50 | 1.20 | 1.30 | -2.00 |
| Debt to assets | – | – | – | – | 0.19 | 0.22 | 0.33 |
| Current ratio | – | – | – | – | 1.25 | 1.04 | 0.79 |
| Quick ratio | – | – | – | – | 0.42 | 0.31 | 0.27 |
| Cash ratio | – | – | – | – | 0.02 | 0.01 | 0.00 |
| Asset turnover | – | – | – | – | 1.04 | 0.87 | 0.74 |
| Fixed asset turnover | – | – | – | – | 3.46 | 2.38 | 2.01 |
| Inventory turnover | – | – | – | – | – | 1.20 | 1.50 |
| Receivables turnover | – | – | – | – | 8.00 | 8.10 | 5.80 |
| Gross margin | – | – | – | – | – | 47.4% | 32.4% |
| Cash from operations to profit | – | – | – | 156.0% | – | 634.0% | – |
| Effective tax rate | – | – | 29.2% | 29.1% | 43.0% | – | – |
A copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
Notice of Postal Ballot
Change in Auditors of the company.
Appointment of S.N Nanda & Co. (FRN: 000685N) as Other of the company w.e.f. September 23, 2026.
A copy Srutinizers report of Annual General Meeting held on September 23, 2026
Voting results of Annual General Meeting held on September 23, 2026
Proceedings of Annual General Meeting held on September 23, 2026